Abstract
e21114 Background: The diagnosis of malignant effusions is established by cytologically and histologically. But, in numerous patients, diagnosis cannot be performed by recurrent cytologic investigations. Tumor markers and cytokines have been worked out for correction the diagnosis. Recent studies report high levels of vascular endothelial growth factor (VEGF) in malignant and inflammatory effusions. VEGF is the most specific mytogenic factor for endothelial cells that has been known. It plays important roles in vasculogenesis and angiogenesis. The aim of the study is to show the calculated VEGF levels in the serum and effusions of patients for the diagnosis of benign and malignant effusions. Methods: 25 patients wtih malignant effusion (patient group) and 25 patients with benign effusion (control group) are included the study. Patient groups were divided into 5 subgroups, which contain 5 patients each (ovarian carcinoma subgroup, breast carcinoma subgroup, lung cancer subgroup, malignant pleural mesotheli...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.